Tag Archives: Lynparza

December, 2018

November, 2018

October, 2018

June, 2018

January, 2018

October, 2017

July, 2017

  • 28 July

    Merck and AstraZeneca Enter Strategic Oncology Collaboration

    ENILWORTH, N.J.–(BUSINESS WIRE)–AstraZeneca and Merck & Co., Inc., (NYSE: MRK), known as MSD outside of the United States and Canada, today announced that they have entered a global strategic oncology collaboration to co-develop and co-commercialize AstraZeneca’s LYNPARZA (olaparib) for multiple cancer types. LYNPARZA is an innovative, first-in-class oral poly ADP …